MCK Quote, Financials, Valuation and Earnings

Cardinal Health has a net margin of 0.26% compared to McKesson's net margin of 0.8%. McKesson's return on equity of -- beat Cardinal Health's return on equity of --.

McKesson has a consensus price target of $651.95, signalling upside risk potential of 12.32%. On the other hand Cardinal Health has an analysts' consensus of $130.61 which suggests that it could grow by 9.18%. Given that McKesson has higher upside potential than Cardinal Health, analysts believe McKesson is more attractive than Cardinal Health.

McKesson has a beta of 0.521, which suggesting that the stock is 47.898% less volatile than S&P 500. In comparison Cardinal Health has a beta of 0.628, suggesting its less volatile than the S&P 500 by 37.189%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.46%. Cardinal Health offers a yield of 1.69% to investors and pays a quarterly dividend of $0.51 per share. McKesson pays 10.46% of its earnings as a dividend. Cardinal Health pays out 58.57% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $93.7B, which are larger than Cardinal Health quarterly revenues of $52.3B. McKesson's net income of $241M is lower than Cardinal Health's net income of $416M. Notably, McKesson's price-to-earnings ratio is 30.06x while Cardinal Health's PE ratio is 23.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.23x versus 0.13x for Cardinal Health. Usually stocks with elevated PS ratios are considered overvalued.

Cencora has a net margin of 0.26% compared to McKesson's net margin of 0%. McKesson's return on equity of -- beat Cencora's return on equity of 157.14%.

McKesson has a consensus price target of $651.95, signalling upside risk potential of 12.32%. On the other hand Cencora has an analysts' consensus of $266.34 which suggests that it could grow by 16.37%. Given that Cencora has higher upside potential than McKesson, analysts believe Cencora is more attractive than McKesson.

McKesson has a beta of 0.521, which suggesting that the stock is 47.898% less volatile than S&P 500. In comparison Cencora has a beta of 0.487, suggesting its less volatile than the S&P 500 by 51.344%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.46%. Cencora offers a yield of 0.91% to investors and pays a quarterly dividend of $0.55 per share. McKesson pays 10.46% of its earnings as a dividend. Cencora pays out 27.58% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $93.7B, which are larger than Cencora quarterly revenues of $79.1B. McKesson's net income of $241M is higher than Cencora's net income of $3.4M. Notably, McKesson's price-to-earnings ratio is 30.06x while Cencora's PE ratio is 30.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.23x versus 0.16x for Cencora. Usually stocks with elevated PS ratios are considered overvalued.

Henry Schein has a net margin of 0.26% compared to McKesson's net margin of 3.12%. McKesson's return on equity of -- beat Henry Schein's return on equity of 6.21%.

McKesson has a consensus price target of $651.95, signalling upside risk potential of 12.32%. On the other hand Henry Schein has an analysts' consensus of $76.08 which suggests that it could grow by 6.03%. Given that McKesson has higher upside potential than Henry Schein, analysts believe McKesson is more attractive than Henry Schein.

McKesson has a beta of 0.521, which suggesting that the stock is 47.898% less volatile than S&P 500. In comparison Henry Schein has a beta of 0.892, suggesting its less volatile than the S&P 500 by 10.818%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.46%. Henry Schein offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. McKesson pays 10.46% of its earnings as a dividend. Henry Schein pays out -- of its earnings as a dividend. McKesson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $93.7B, which are larger than Henry Schein quarterly revenues of $3.2B. McKesson's net income of $241M is higher than Henry Schein's net income of $99M. Notably, McKesson's price-to-earnings ratio is 30.06x while Henry Schein's PE ratio is 29.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.23x versus 0.74x for Henry Schein. Usually stocks with elevated PS ratios are considered overvalued.

Pineapple has a net margin of 0.26% compared to McKesson's net margin of --. McKesson's return on equity of -- beat Pineapple's return on equity of --.

McKesson has a consensus price target of $651.95, signalling upside risk potential of 12.32%. On the other hand Pineapple has an analysts' consensus of -- which suggests that it could fall by --. Given that McKesson has higher upside potential than Pineapple, analysts believe McKesson is more attractive than Pineapple.

McKesson has a beta of 0.521, which suggesting that the stock is 47.898% less volatile than S&P 500. In comparison Pineapple has a beta of 28.779, suggesting its more volatile than the S&P 500 by 2777.907%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.46%. Pineapple offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. McKesson pays 10.46% of its earnings as a dividend. Pineapple pays out -- of its earnings as a dividend. McKesson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $93.7B, which are larger than Pineapple quarterly revenues of --. McKesson's net income of $241M is higher than Pineapple's net income of --. Notably, McKesson's price-to-earnings ratio is 30.06x while Pineapple's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.23x versus 61.43x for Pineapple. Usually stocks with elevated PS ratios are considered overvalued.